These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35022652)

  • 1. Genetically identical twins show comparable tau PET load and spatial distribution.
    Coomans EM; Tomassen J; Ossenkoppele R; Golla SSV; den Hollander M; Collij LE; Weltings E; van der Landen SM; Wolters EE; Windhorst AD; Barkhof F; de Geus EJC; Scheltens P; Visser PJ; van Berckel BNM; den Braber A
    Brain; 2022 Oct; 145(10):3571-3581. PubMed ID: 35022652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Coomans EM; Tomassen J; Ossenkoppele R; Tijms BM; Lorenzini L; Ten Kate M; Collij LE; Heeman F; Rikken RM; van der Landen SM; den Hollander ME; Golla SSV; Yaqub M; Windhorst AD; Barkhof F; Scheltens P; de Geus EJC; Visser PJ; van Berckel BNM; den Braber A
    Brain; 2023 Sep; 146(9):3735-3746. PubMed ID: 36892415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
    Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
    Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional [
    Wolters EE; Ossenkoppele R; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Golla SSV; Windhorst AD; Boellaard R; van der Flier WM; Teunissen CE; Scheltens P; van Berckel BNM
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2866-2878. PubMed ID: 32291510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
    Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
    JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.
    Visser D; Verfaillie SCJ; Wolters EE; Coomans EM; Timmers T; Tuncel H; Boellaard R; Golla SSV; Windhorst AD; Scheltens P; van der Flier WM; van Berckel BNM; Ossenkoppele R
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1951-1963. PubMed ID: 34997294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
    Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Tanner JA; Iaccarino L; Edwards L; Asken BM; Gorno-Tempini ML; Kramer JH; Pham J; Perry DC; Possin K; Malpetti M; Mellinger T; Miller BL; Miller Z; Mundada NS; Rosen HJ; Soleimani-Meigooni DN; Strom A; La Joie R; Rabinovici GD
    Brain; 2022 Dec; 145(12):4489-4505. PubMed ID: 35762829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of Preclinical Alzheimer Disease in Monozygotic Twins.
    Konijnenberg E; Tomassen J; den Braber A; Ten Kate M; Yaqub M; Mulder SD; Nivard MG; Vanderstichele H; Lammertsma AA; Teunissen CE; van Berckel BNM; Boomsma DI; Scheltens P; Tijms BM; Visser PJ
    Ann Neurol; 2021 May; 89(5):987-1000. PubMed ID: 33583080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.
    Fleisher AS; Pontecorvo MJ; Devous MD; Lu M; Arora AK; Truocchio SP; Aldea P; Flitter M; Locascio T; Devine M; Siderowf A; Beach TG; Montine TJ; Serrano GE; Curtis C; Perrin A; Salloway S; Daniel M; Wellman C; Joshi AD; Irwin DJ; Lowe VJ; Seeley WW; Ikonomovic MD; Masdeu JC; Kennedy I; Harris T; Navitsky M; Southekal S; Mintun MA;
    JAMA Neurol; 2020 Jul; 77(7):829-839. PubMed ID: 32338734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal [
    Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
    Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tau pathology is associated with synaptic loss and altered synaptic function.
    Coomans EM; Schoonhoven DN; Tuncel H; Verfaillie SCJ; Wolters EE; Boellaard R; Ossenkoppele R; den Braber A; Scheper W; Schober P; Sweeney SP; Ryan JM; Schuit RC; Windhorst AD; Barkhof F; Scheltens P; Golla SSV; Hillebrand A; Gouw AA; van Berckel BNM
    Alzheimers Res Ther; 2021 Feb; 13(1):35. PubMed ID: 33546722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's disease.
    Visser D; Wolters EE; Verfaillie SCJ; Coomans EM; Timmers T; Tuncel H; Reimand J; Boellaard R; Windhorst AD; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3165-3175. PubMed ID: 32462397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age-related tauopathy and Alzheimer's disease.
    Josephs KA; Tosakulwong N; Weigand SD; Graff-Radford J; Schwarz CG; Senjem ML; Machulda MM; Kantarci K; Knopman DS; Nguyen A; Reichard RR; Dickson DW; Petersen RC; Lowe VJ; Jack CR; Whitwell JL
    Sci Transl Med; 2024 Jul; 16(757):eado8076. PubMed ID: 39047115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.